[5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS
    5.
    发明公开
    [5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS 审中-公开
    [5,6] - 邻苯二甲酸酯类抗生素VERBINDUNGEN

    公开(公告)号:EP3177285A1

    公开(公告)日:2017-06-14

    申请号:EP15829495.9

    申请日:2015-08-03

    Abstract: Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

    Abstract translation: 结构式(I)的新型化合物及其药学上可接受的盐是G蛋白偶联受体40(GPR40)的激动剂,可用于治疗,预防和抑制G蛋白偶联受体 受体40.本发明的化合物可用于治疗2型糖尿病,以及通常与该疾病相关的病症,包括肥胖症和脂质疾病,例如混合或糖尿病性血脂异常,高脂血症,高胆固醇血症和 高甘油三酯血症。

Patent Agency Ranking